🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
COPE is a biology driven protocol with 2 independent, multicentric, two-arm...
Status
Active Not Recruiting
Location
Centre hospitalier de la Côte Basque
Start Date
2020-09-04
Trial ID
NCT04258137
Treatments Being Tested
The study aims to develop PRIME (PRostate cancer plasma Integrative Multi-m...
Status
Recruiting
Location
Istituto Romagnolo per lo Studio dei Tumori
Start Date
2019-05-07
Trial ID
NCT06981377
Liquid biopsy has been successfully applied to the treatment and diagnosis ...
Status
Unknown
Location
Rongbo Lin
Start Date
2018-07-01
Trial ID
NCT03476057
Treatments Being Tested
The purpose of this study is to determine whether shotgun sequencing techno...
Status
Completed
Location
Kaiser Permanente Northern California
Start Date
2010-03
Trial ID
NCT01985412
Pilot, prospective, mono-center study conducted in a population of healthy ...
Status
Completed
Location
Institut Universitaire du Cancer de Toulouse - Oncopole
Start Date
2026-07-16
Trial ID
NCT07663994
Treatments Being Tested
This pilot research trial studies circulating tumor deoxyribonucleic acid (...
Status
Completed
Location
Thomas Jefferson University
Start Date
2014-07-22
Trial ID
NCT02245100
Treatments Being Tested
third generation of EGFR-TKIs is the newest target therapy for NSCLC. Howev...
Status
Unknown
Location
Sun Yat-Sen University Cancer Center
Start Date
2016-04
Trial ID
NCT02738593
The goal of this study is to develop an effective, sensitive blood test tha...
Status
Active Not Recruiting
Location
BC Cancer Agency
Start Date
2018-07-01
Trial ID
NCT04261972
Treatments Being Tested
The objective of this study is to predict subclinical Antibody-Mediated Rej...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2022-12-26
Trial ID
NCT06013358
Treatments Being Tested
Currently, the molecular characterization of onco-hematological, onco-immun...
Status
Recruiting
Location
Meyer Children's Hospital IRCCS
Start Date
2023-07-05
Trial ID
NCT06304194
Treatments Being Tested